Lemay Avenue Health And Rehabilitation Facility | |
4824 S Lemay Ave, Fort Collins, Colorado 80525 | |
(970) 482-1584 | |
Name | Lemay Avenue Health And Rehabilitation Facility |
---|---|
Location | 4824 S Lemay Ave, Fort Collins, Colorado |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 130 |
Occupancy Rate | 81.62% |
Medicare ID (CCN) | 065142 |
Legal Business Name | Greenfield Management Services, Inc. |
Ownership Type | For Profit - Corporation |
NPI Number | 1881743102 |
Organization Name | GREENFIELD MANAGEMENT SERVICES, INC. |
Doing Business As | COLUMBINE CARE CENTER EAST |
Address | 4824 S Lemay Ave, Fort Collins, CO 80525 |
Phone Number | 970-482-1584 |
News Archive
Physicians will be able to predict which of their patients with severe asthma are likely to benefit from treatment with systemic corticosteroids - and which might only suffer their side effects - with help from a dozen clinical variables researchers have identified using machine learning techniques.
The new influenza drug Xofluza, developed by the Japanese pharmaceutical company Shionogi, was approved for clinical use in Japan in February 2018.
Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, announces the issuance of patent 4810095 entitled "Use of Protein Kinase N beta" by the Japanese Patent Office.
After examining data from government health surveys undertaken in the United States, researchers say more American women are developing a type of artery disease that raises the risk of death from heart disease and stroke.
› Verified 7 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Physicians will be able to predict which of their patients with severe asthma are likely to benefit from treatment with systemic corticosteroids - and which might only suffer their side effects - with help from a dozen clinical variables researchers have identified using machine learning techniques.
The new influenza drug Xofluza, developed by the Japanese pharmaceutical company Shionogi, was approved for clinical use in Japan in February 2018.
Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, announces the issuance of patent 4810095 entitled "Use of Protein Kinase N beta" by the Japanese Patent Office.
After examining data from government health surveys undertaken in the United States, researchers say more American women are developing a type of artery disease that raises the risk of death from heart disease and stroke.
› Verified 7 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 16.36 | 14.46 |
Percentage of long-stay residents who lose too much weight | 3.91 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 55.1 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.88 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 4.05 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.86 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 3.81 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 16.2 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.76 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0.53 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 25.8 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 18.73 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 5.5 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.37 | 95.98 |
Percentage of short-stay residents who made improvements in function | 77.9 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.36 | 82.93 |
News Archive
Physicians will be able to predict which of their patients with severe asthma are likely to benefit from treatment with systemic corticosteroids - and which might only suffer their side effects - with help from a dozen clinical variables researchers have identified using machine learning techniques.
The new influenza drug Xofluza, developed by the Japanese pharmaceutical company Shionogi, was approved for clinical use in Japan in February 2018.
Silence Therapeutics plc, a leading RNA interference (RNAi) therapeutics company, announces the issuance of patent 4810095 entitled "Use of Protein Kinase N beta" by the Japanese Patent Office.
After examining data from government health surveys undertaken in the United States, researchers say more American women are developing a type of artery disease that raises the risk of death from heart disease and stroke.
› Verified 7 days ago
Lemay Avenue Health And Rehabilitation Facility Location: 4824 S Lemay Ave, Fort Collins, Colorado 80525 Phone: (970) 482-1584 | |
Fort Collins Health Care Center Location: 1000 S Lemay Ave, Fort Collins, Colorado 80524 Phone: (970) 482-7925 | |
Rehabilitation And Nursing Center Of The Rockies Location: 1020 Patton St, Fort Collins, Colorado 80524 Phone: (970) 484-7981 | |
Spring Creek Health Care Center Location: 1000 E Stuart St, Fort Collins, Colorado 80525 Phone: (970) 482-5712 | |
Good Samaritan Society - Fort Collins Village Location: 508 W Trilby Rd, Fort Collins, Colorado 80525 Phone: (970) 226-4909 | |
Columbine West Health And Rehab Facility Location: 940 Worthington Cir, Fort Collins, Colorado 80526 Phone: (970) 221-2273 |